NO20020784D0 - Medication for the treatment of fractures - Google Patents

Medication for the treatment of fractures

Info

Publication number
NO20020784D0
NO20020784D0 NO20020784A NO20020784A NO20020784D0 NO 20020784 D0 NO20020784 D0 NO 20020784D0 NO 20020784 A NO20020784 A NO 20020784A NO 20020784 A NO20020784 A NO 20020784A NO 20020784 D0 NO20020784 D0 NO 20020784D0
Authority
NO
Norway
Prior art keywords
fractures
medication
treatment
Prior art date
Application number
NO20020784A
Other languages
Norwegian (no)
Other versions
NO20020784L (en
Inventor
David G Little
Original Assignee
Royal Alexandra Hosp Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hosp Children filed Critical Royal Alexandra Hosp Children
Publication of NO20020784L publication Critical patent/NO20020784L/en
Publication of NO20020784D0 publication Critical patent/NO20020784D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
NO20020784A 1999-08-19 2002-02-18 Medication for the treatment of fractures NO20020784D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures
PCT/AU2000/000982 WO2001013922A1 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Publications (2)

Publication Number Publication Date
NO20020784L NO20020784L (en) 2002-02-18
NO20020784D0 true NO20020784D0 (en) 2002-02-18

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020784A NO20020784D0 (en) 1999-08-19 2002-02-18 Medication for the treatment of fractures

Country Status (16)

Country Link
EP (1) EP1214079A4 (en)
JP (1) JP2003507426A (en)
KR (1) KR20020027562A (en)
CN (1) CN100345548C (en)
AU (1) AUPQ232599A0 (en)
BR (1) BR0013416A (en)
CA (1) CA2381302A1 (en)
HK (1) HK1048441B (en)
HU (1) HUP0202396A3 (en)
IL (1) IL148166A0 (en)
NO (1) NO20020784D0 (en)
NZ (1) NZ517538A (en)
PL (1) PL353485A1 (en)
SK (1) SK2382002A3 (en)
WO (1) WO2001013922A1 (en)
ZA (1) ZA200202160B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030072399A (en) * 2001-02-06 2003-09-13 더 로얄 알렉산드라 호스피탈 포 칠드런 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
EP1383509A4 (en) * 2001-04-03 2005-10-26 Royal Alexandra Hosp Children A drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
ES2561463T3 (en) * 2003-08-21 2016-02-26 Addbio Ab Implant device coated with bisphosphonate and method for it
CN1852719A (en) * 2003-09-19 2006-10-25 辉瑞产品公司 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
ITMI20040218A1 (en) * 2004-02-10 2004-05-10 Abiogen Pharma Spa USE OF SODIUM NERHYDRONATE TO PROMOTE BONE NEOFORMATION
ITMI20040641A1 (en) * 2004-03-31 2004-06-30 Tb Technology S R L BIFUNCTIONAL BIOADHESIVE COMPOSITIONS FOR ORAL IMPLANTOLOGY
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
EP1940339B1 (en) 2005-10-27 2011-12-21 Thommen Medical Ag Dental implant and production method for said implant
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (en) * 1981-11-19 1983-07-05 Luiz Romariz Duarte ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION
EP0618805A1 (en) * 1991-12-17 1994-10-12 PROCTER & GAMBLE PHARMACEUTICALS, INC. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
CA2151240A1 (en) * 1992-12-23 1994-07-07 Donna T. Whiteford Biophosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
EP0831843A1 (en) * 1995-06-06 1998-04-01 Merck & Co., Inc. Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
NO20020784L (en) 2002-02-18
ZA200202160B (en) 2003-08-27
WO2001013922A1 (en) 2001-03-01
BR0013416A (en) 2002-04-30
CN100345548C (en) 2007-10-31
NZ517538A (en) 2003-07-25
KR20020027562A (en) 2002-04-13
IL148166A0 (en) 2002-09-12
HUP0202396A3 (en) 2005-02-28
HK1048441A1 (en) 2003-04-04
EP1214079A1 (en) 2002-06-19
AUPQ232599A0 (en) 1999-09-09
EP1214079A4 (en) 2004-03-24
SK2382002A3 (en) 2002-09-10
JP2003507426A (en) 2003-02-25
HUP0202396A2 (en) 2002-11-28
CA2381302A1 (en) 2001-03-01
HK1048441B (en) 2008-02-22
PL353485A1 (en) 2003-11-17
CN1370071A (en) 2002-09-18

Similar Documents

Publication Publication Date Title
NO20013380D0 (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20014379D0 (en) Use of Xenon for the Treatment of Neurointoxics
DE60142473D1 (en) INTRAKORPORAL MEDICAMENTS FOR THE PHOTODYNAMIC TREATMENT OF ILLNESSES
NO20022087L (en) Procedure for the treatment of diabetes
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20013958L (en) Medication for the treatment of high blood pressure
NO20005179D0 (en) Drug treatment
NO20033804D0 (en) Carbamate compounds for the treatment of pain
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776D0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20020784D0 (en) Medication for the treatment of fractures
NO20012106D0 (en) Drug for the treatment of bone pathobolism
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20013651D0 (en) Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections
PT1200447E (en) OXAZINOCARBAZOLES FOR THE TREATMENT OF DISEASES OF THE SNC
NO20014026L (en) Antispasmodic derivatives for the treatment of significant tremor
IS2153B (en) S-nitrosothiol for the treatment of circulatory disorders
NO20012540D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20014477D0 (en) Treatment of osteoarthritis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application